This study investigates pancreatic cancer. It focuses on detecting circulating tumor cells (CTCs) that express AXL using advanced techniques.
The study evaluates the effectiveness of two methods for detecting AXL(+) CTCs. It looks at how well these methods work for understanding the progression of pancreatic cancer.
- Who can participate: Adults aged 18 and older with pancreatic cancer that has spread and who have not received treatment can participate. Oral consent is required.
- Study details: Participants will have their blood tested to detect circulating tumor cells using two different methods.